Multi-Agency Informational Meeting Concerning Compliance With the Import Permit Program; Public Webcast, 47467-47468 [2014-19114]
Download as PDF
47467
Federal Register / Vol. 79, No. 156 / Wednesday, August 13, 2014 / Notices
can influence levels of substances in the
home such as volatile organic
compounds (VOCs), more study sites in
different geographic locations will help
scientists understand if these
relationships hold in different climates
and housing stock. This ongoing study
provides a foundation to explore the
potential for green affordable housing to
promote healthy homes principles. This
will be accomplished by gathering data
from a total of thirteen study sites across
the United States.
Study participants will continue to
include children with asthma and their
mothers/primary caregivers living in
HUD-subsidized housing that has either
been scheduled to receive a green
renovation or is a comparison home
(i.e., no renovation). The following are
eligible for the study: (1) Children age
7–12 years with asthma and (2)
mothers/primary caregivers. The length
of follow-up is one year. Questionnaires
regarding home characteristics and
respiratory symptoms of the children
will be administered at 1- to 6-month
intervals. Environmental sampling of
the air and dust in the respondents’
homes will be conducted over a 1-year
period: Once in the home before
rehabilitation (Baseline), and then at
three time points after rehabilitation has
been completed (Baseline Part 2, 6
months, and 12 months).
The response rate from enrollment
through the end of data collection for
the first two study sites was 82%. The
expected response rate for the overall
study is 80%. To reach the desired
number of respondents approximately
1,000 adults (mothers/primary
caregivers) will need to complete the
screening forms. Approximately 832
mothers/primary caregivers of enrolled
children will complete the
questionnaires. All health and
environmental exposure information
about children will be provided by their
mothers/primary caregivers (i.e., no
children will fill out questionnaires).
There is no cost to the respondents
other than their time to participate in
the study. The total estimated annual
burden hours equals 2,356.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Mothers/Primary
asthma.
Mothers/Primary
dren.
Mothers/Primary
dren.
Mothers/Primary
dren.
Mothers/Primary
dren.
Mothers/Primary
dren.
Mothers/Primary
dren.
Mothers/Primary
dren.
Mothers/Primary
dren.
Mothers/Primary
dren.
Mothers/Primary
dren.
Mothers/Primary
dren.
Number of
respondents
Form name
Screening Questionnaire ................................
1,000
1
10/60
caregivers of enrolled chil-
Baseline Questionnaire (Home Characteristics).
Baseline (Part 2) Questionnaire (Home Characteristics).
Baseline Questionnaire (Demographics) .......
832
1
15/60
832
1
5/60
832
1
5/60
Baseline Questionnaire (Children 7–12 with
Asthma).
Text Messages (Children 7–12 with Asthma)
832
1
15/60
832
8
1/60
3 and 9-month Follow-up Questionnaire
(Children 7–12 with Asthma).
6 and 12-month Follow-up Questionnaire
(Environment).
6 and 12-month Follow-up Questionnaire
(Children 7–12 with Asthma).
Time/Activity Questionnaire (Children with
Asthma 7–12 years).
Time/Activity Questionnaire (Mother/Primary
Caregiver).
Illness Checklist .............................................
832
2
5/60
832
2
10/60
832
2
10/60
832
4
5/60
832
4
5/60
832
4
5/60
caregivers of enrolled chilcaregivers of enrolled chilcaregivers of enrolled chilcaregivers of enrolled chilcaregivers of enrolled chilcaregivers of enrolled chilcaregivers of enrolled chilcaregivers of enrolled chilcaregivers of enrolled chilcaregivers of enrolled chil-
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–19104 Filed 8–12–14; 8:45 am]
Multi-Agency Informational Meeting
Concerning Compliance With the
Import Permit Program; Public
Webcast
BILLING CODE 4163–18–P
mstockstill on DSK4VPTVN1PROD with NOTICES
Average
burden
per response
(in hrs)
caregivers of children with
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of public webcast.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) located
within the United States Department of
SUMMARY:
VerDate Mar<15>2010
Number of
responses per
respondent
18:15 Aug 12, 2014
Jkt 232001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Health and Human Services (HHS)
announces a public webcast for all
individuals who apply for permits to
import (1) infectious biological agents,
infectious substances, or vectors known
to transfer or that are capable of
transferring an infectious biological
agent to a human; and (2) import items
that contain or may contain dangerous
agricultural pests and diseases. The
purpose of the webcast is to provide
guidance related to the import permit
program.
The webcast will be held on
Friday, October 24, 2014 from 1 p.m. to
5 p.m. EST. Those wishing to join the
webcast must register by October 1,
2014. Registration instructions can be
DATES:
E:\FR\FM\13AUN1.SGM
13AUN1
47468
Federal Register / Vol. 79, No. 156 / Wednesday, August 13, 2014 / Notices
found on the Web site https://
www.cdc.gov/od/eaipp/.
ADDRESSES: The webcast will be
broadcast from the Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT: Von
McClee, Division of Select Agents and
Toxins, Office of Public Health
Preparedness and Response, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS A–46, Atlanta, GA
30333; phone: 404–718–2000; email:
lrsat@cdc.gov.
SUPPLEMENTARY INFORMATION: This
webcast is an opportunity for the
affected community (i.e., academic
institutions and biomedical centers;
commercial manufacturing facilities;
federal, state, and local laboratories,
including clinical and diagnostic
laboratories; research facilities;
exhibition facilities; and educational
facilities) and other interested
individuals to obtain specific guidance
and information regarding the import
permit program. The webcast will also
provide assistance to those interested in
applying for an import permit.
Representatives from the Department
of Transportation, U.S. Department of
Agriculture/Animal and Plant Health
Inspection Service, and HHS/CDC will
be present during the webcast to address
questions and concerns from the web
participants.
Individuals who want to participate
in the webcast must complete their
registration online by October 1, 2014.
The registration instructions are located
on this Web site: https://www.cdc.gov/
od/eaipp/. This is a 100% webcast;
therefore, no accommodations exist for
in-person participation.
Dated: August 8, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2014–19114 Filed 8–12–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Administration for Community Living
Notice of Meeting of the President’s
Committee for People With Intellectual
Disabilities (PCPID)
Administration on Intellectual
and Developmental Disabilities (AIDD
Administration for Community Living
(ACL), Department of Health and
Human Services.
ACTION: Notice of meeting.
AGENCY:
VerDate Mar<15>2010
18:15 Aug 12, 2014
Jkt 232001
Wednesday, September 3, 2014
from 9:30 a.m. to 5:00 p.m.; Thursday,
September 4, 2014 from 9:00 a.m. to
5:00 p.m., and Friday, September 5,
2014 from 9:00 a.m. to 4:00 p.m. (EST).
These meetings will be open to the
general public.
ADDRESSES: These meetings will be held
in the U.S. Department of Health and
Human Services/Hubert H. Humphrey
Building located at 200 Independence
Avenue SW., Conference Room 505A,
Washington, DC 20201.
Individuals who would like to
participate via conference call may do
so by dialing toll-free 888–566–6303,
when prompted enter pass code: 45348.
Individuals whose full participation in
the meeting will require special
accommodations (e.g., sign language
interpreting services, assistive listening
devices, materials in alternative format
such as large print or Braille) should
notify Dr. MJ Karimi, PCPID Team Lead,
via email at MJ.Karimie@acl.hhs.gov, or
via telephone at 202–619–3165, no later
than Wednesday, August 27, 2014. The
PCPID will attempt to accommodate
requests made after that date, but cannot
guarantee the ability to grant requests
received after this deadline. All meeting
sites are barrier free, consistent with the
Americans with Disabilities Act (ADA)
and the Federal Advisory Committee
Act (FACA).
Agenda: PCPID Appointees will be
sworn-in as Members and receive
Departmental training for Special
Government Employees. The Committee
Members will discuss potential topics,
themes, and trends for the PCPID
Annual Report to the President.
Additional Information: For further
information, please contact Dr. MJ
Karimi, Team Lead, President’s
Committee for People with Intellectual
Disabilities, 200 Independence Avenue
SW., Room 637D, Washington, DC
20201. Telephone: 202–205–3165. Fax:
202–260–3053. Email: MJ.Karimie@
acl.hhs.gov.
SUPPLEMENTARY INFORMATION: The
PCPID acts in an advisory capacity to
the President and the Secretary of
Health and Human Services, through
the Administration on Intellectual and
Developmental Disabilities, on a broad
range of topics relating to programs,
services and supports for persons with
intellectual disabilities. The PCPID
Executive Order stipulates that the
Committee shall: (1) Provide such
advice concerning intellectual
disabilities as the President or the
Secretary of Health and Human Services
may request; and (2) provide advice to
the President concerning the following
for people with intellectual disabilities:
DATES:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
(A) Expansion of educational
opportunities; (B) promotion of
homeownership; (C) assurance of
workplace integration; (D) improvement
of transportation options; (E) expansion
of full access to community living; and
(F) increasing access to assistive and
universally designed technologies.
Dated: August 7, 2014.
Aaron Bishop,
Commissioner, Administration on Intellectual
and Developmental Disabilities (AIDD).
[FR Doc. 2014–19164 Filed 8–12–14; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: Identification of Non-Invasive
Biomarkers of Coordinate Metabolic
Reprogramming in Colorectal Tumor
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This is notice, in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
that the National Institutes of Health,
Department of Health and Human
Services, is contemplating the grant of
an exclusive patent license to practice
the inventions embodied in the
following U.S. Patents and Patent
Applications to Cary Pharmaceuticals,
Inc. (‘‘Cary’’) located in Great Falls, VA,
USA.
SUMMARY:
Intellectual Property
1. United States Provisional Patent
No. 61/755,891, issued January 23,
2013, entitled ‘‘Identification of Noninvasive Biomarkers of Coordinate
Metabolic Reprograming Colorectal
Tumor’’;
2. International Patent Application
No. PCT/US2014/012758 filed January
23, 2014 entitled ‘‘Compositions and
Methods for Detecting Neoplasia’’ [HHS
Reference No. E–020–2013/0–PCT–02]
The patent rights in these inventions
have been assigned to the government of
the United States of America.
The prospective exclusive license
territory may be worldwide and the
field of use will be limited to the use of
Licensed Patent Rights for the
commercial development of an FDA
approved diagnostic/prognostic kit or a
class III diagnostic test for human
colorectal adenoma (non-malignant
polyp) and carcinoma.
DATES: Only written comments and/or
applications for a license which are
received by the NIH Office of
E:\FR\FM\13AUN1.SGM
13AUN1
Agencies
[Federal Register Volume 79, Number 156 (Wednesday, August 13, 2014)]
[Notices]
[Pages 47467-47468]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-19114]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Multi-Agency Informational Meeting Concerning Compliance With the
Import Permit Program; Public Webcast
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of public webcast.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) located
within the United States Department of Health and Human Services (HHS)
announces a public webcast for all individuals who apply for permits to
import (1) infectious biological agents, infectious substances, or
vectors known to transfer or that are capable of transferring an
infectious biological agent to a human; and (2) import items that
contain or may contain dangerous agricultural pests and diseases. The
purpose of the webcast is to provide guidance related to the import
permit program.
DATES: The webcast will be held on Friday, October 24, 2014 from 1 p.m.
to 5 p.m. EST. Those wishing to join the webcast must register by
October 1, 2014. Registration instructions can be
[[Page 47468]]
found on the Web site https://www.cdc.gov/od/eaipp/.
ADDRESSES: The webcast will be broadcast from the Centers for Disease
Control and Prevention, 1600 Clifton Road NE., Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT: Von McClee, Division of Select Agents
and Toxins, Office of Public Health Preparedness and Response, Centers
for Disease Control and Prevention, 1600 Clifton Road NE., MS A-46,
Atlanta, GA 30333; phone: 404-718-2000; email: lrsat@cdc.gov.
SUPPLEMENTARY INFORMATION: This webcast is an opportunity for the
affected community (i.e., academic institutions and biomedical centers;
commercial manufacturing facilities; federal, state, and local
laboratories, including clinical and diagnostic laboratories; research
facilities; exhibition facilities; and educational facilities) and
other interested individuals to obtain specific guidance and
information regarding the import permit program. The webcast will also
provide assistance to those interested in applying for an import
permit.
Representatives from the Department of Transportation, U.S.
Department of Agriculture/Animal and Plant Health Inspection Service,
and HHS/CDC will be present during the webcast to address questions and
concerns from the web participants.
Individuals who want to participate in the webcast must complete
their registration online by October 1, 2014. The registration
instructions are located on this Web site: https://www.cdc.gov/od/eaipp/
. This is a 100% webcast; therefore, no accommodations exist for in-
person participation.
Dated: August 8, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science, Centers for Disease
Control and Prevention.
[FR Doc. 2014-19114 Filed 8-12-14; 8:45 am]
BILLING CODE 4163-18-P